| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.43 | 0.2 |